ArticleMolecular therapy. Oncology2024

Drug repurposing screen targeting PARP identifies cytotoxic activity of efavirenz in high-grade serous ovarian cancer.

Bayley Matthews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.